Skip to content
10-K/A

Annual Report

Regulus Therapeutics Inc.

0001193125-25-107128

← back to feed
Filed
Apr 30, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 7, 2025 66.24M sh